| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
14 |
| Employees |
41 |
| Revenues (TTM) (Millions $) |
7 |
| Net Income (TTM) (Millions $) |
-6 |
| Cash Flow (TTM) (Millions $) |
204 |
| Capital Exp. (TTM) (Millions $) |
3 |
Business Description
Pandion Therapeutics Inc is a biotechnology company that is focused on the development of immune system therapies for patients with autoimmune and inflammatory diseases. The company was founded in 2017 and is headquartered in Massachusetts, USA.
The company is led by a team of experienced biotech executives with cutting-edge research expertise. The leadership team has a proven track record of developing and commercializing innovative therapies that have changed the landscape of medicine.
Pandion Therapeutics Inc is focused on the development of Treg science which is a promising new approach to treating autoimmune and inflammatory diseases. According to their official website, they are aiming to:
Create the next generation of targeted immune modulation therapies.
Develop safe, selective Treg-based therapeutics.
Utilize cutting-edge drug design and protein engineering techniques to create transformative therapies.
Partner with biopharmaceutical companies to bring innovative therapies to the market.
The company is dedicated to advancing the understanding of Tregs' biological functions and mechanisms of action. This research is critical for identifying targets and developing therapeutics that can activate or inhibit Tregs as needed to treat diseases.
Pandion Therapeutics Inc has already built a robust pipeline of potential Treg-based therapies that are in various stages of development. Their current portfolio includes multiple candidates for the treatment of autoimmune and inflammatory diseases such as ulcerative colitis, celiac disease, type 1 diabetes, and multiple sclerosis.
Overall, Pandion Therapeutics Inc is dedicated to serving patients with autoimmune and inflammatory diseases by developing innovative therapies that can improve their lives. They hope to leverage their expertise and partnerships to bring transformative therapies to the market and make a significant impact.
Company Address: 134 Coolidge Avenue Watertown 2472 MA
Company Phone Number: 393-5925 Stock Exchange / Ticker: NASDAQ PAND
|
%